Lakefront Biotherapeutics (GLPGF) Other Working Capital Changes (2018 - 2020)

Lakefront Biotherapeutics (GLPGF) has reported Other Working Capital Changes for 11 consecutive years, with -$597080.3 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 99.04% year-over-year to -$597080.3 in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 366.75% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 337.68% from the prior year.
• Other Working Capital Changes was -$597080.3 for Q1 2026 at Lakefront Biotherapeutics, up from -$1.0 billion in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $88.8 million in Q2 2024 and troughed at -$1.0 billion in Q4 2025.
• A 3-year average of $98022.3 and a median of $98886.7 in 2019 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes gained 3.19% in 2019 and climbed 0.47% in 2020, its largest moves.
• Over 5 years, Other Working Capital Changes stood at -$391.4 million in 2022, then slumped by 81.73% to -$711.3 million in 2023, then soared by 91.5% to -$60.5 million in 2024, then sank by 1625.78% to -$1.0 billion in 2025, then soared by 99.94% to -$597080.3 in 2026.
• The last three Other Working Capital Changes figures came in at -$597080.3 (Q1 2026), -$1.0 billion (Q4 2025), and -$205.3 million (Q3 2025), per Business Quant data.